SOHM, which exports generic pharmaceuticals globally, with a focus on distribution in emerging markets in Africa, Latin America and Southeast Asia, has inked a letter of intent (LOI) to take over an India-based dermatology company.
Subscribe to our email newsletter
Once the acquisition is completed, SOHM expects to add 17 new product offerings.
SOHM president and CEO Shailesh Shah said they not only gain new products to further diversify their offerings, but increase the revenue and brand awareness significantly throughout India and the entire Asian region.
"The signing of this LOI is a big step forward in realizing the revenue and product line growth we have projected for 2011," Shah said.
Closing of the acquisition is expected in Q2 of fiscal 2011.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.